These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8174053)

  • 1. Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experience.
    Eden BV; Debo RF; Larner JM; Kelly MD; Levine PA; Stewart FM; Cantrell RW; Constable WC
    Cancer; 1994 May; 73(10):2556-62. PubMed ID: 8174053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Craniofacial resection at the University of Virginia (1976-1992): survival analysis.
    Levine PA; Debo RF; Meredith SD; Jane JA; Constable WC; Cantrell RW
    Head Neck; 1994; 16(6):574-7. PubMed ID: 7822181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
    El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence.
    Petruzzelli GJ; Howell JB; Pederson A; Origitano TC; Byrne RW; Munoz L; Emami B; Clark JI
    Am J Otolaryngol; 2015; 36(4):547-53. PubMed ID: 25749259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of long-term outcomes for patients with esthesioneuroblastoma.
    Ow TJ; Hanna EY; Roberts DB; Levine NB; El-Naggar AK; Rosenthal DI; DeMonte F; Kupferman ME
    Head Neck; 2014 Apr; 36(4):524-30. PubMed ID: 23780581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esthesioneuroblastoma: the University of Iowa experience 1978-1998.
    Simon JH; Zhen W; McCulloch TM; Hoffman HT; Paulino AC; Mayr NA; Buatti JM
    Laryngoscope; 2001 Mar; 111(3):488-93. PubMed ID: 11224781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
    Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
    Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Olfactory neuroblastoma: the Hokkaido University experience].
    Kano S; Furuta Y; Homma A; Oridate N; Higuchi E; Suzuki F; Nagahashi T; Sawamura Y; Fukuda S
    Nihon Jibiinkoka Gakkai Kaiho; 2006 May; 109(5):433-9. PubMed ID: 16768158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esthesioneuroblastoma: the impact of treatment modality.
    Chao KS; Kaplan C; Simpson JR; Haughey B; Spector GJ; Sessions DG; Arquette M
    Head Neck; 2001 Sep; 23(9):749-57. PubMed ID: 11505485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
    de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
    Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
    McElroy EA; Buckner JC; Lewis JE
    Neurosurgery; 1998 May; 42(5):1023-7; discussion 1027-8. PubMed ID: 9588546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
    Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
    J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modality therapy of esthesioneuroblastoma.
    McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
    Rastogi M; Bhatt M; Chufal K; Srivastava M; Pant M; Srivastava K; Mehrotra S
    Jpn J Clin Oncol; 2006 Oct; 36(10):613-9. PubMed ID: 16926225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
    Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
    BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients.
    Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
    Radiat Oncol; 2020 Sep; 15(1):219. PubMed ID: 32948223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.